nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—HDAC2—Teniposide—Etoposide—testicular cancer	0.0309	1	CbGdCrCtD
Oxtriphylline—PDE4C—G alpha (s) signalling events—INSL3—testicular cancer	0.0237	0.0374	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.0227	0.0358	CbGpPWpGaD
Oxtriphylline—HDAC2—embryo—testicular cancer	0.0227	0.0679	CbGeAlD
Oxtriphylline—PDE3B—PKB-mediated events—STK11—testicular cancer	0.022	0.0346	CbGpPWpGaD
Oxtriphylline—ADORA2B—G alpha (s) signalling events—INSL3—testicular cancer	0.0216	0.0341	CbGpPWpGaD
Oxtriphylline—PDE3B—G alpha (s) signalling events—INSL3—testicular cancer	0.021	0.0331	CbGpPWpGaD
Oxtriphylline—PDE4D—G alpha (s) signalling events—INSL3—testicular cancer	0.0206	0.0325	CbGpPWpGaD
Oxtriphylline—PDE4A—G alpha (s) signalling events—INSL3—testicular cancer	0.0197	0.031	CbGpPWpGaD
Oxtriphylline—PDE3A—G alpha (s) signalling events—INSL3—testicular cancer	0.0191	0.0301	CbGpPWpGaD
Oxtriphylline—PDE3B—testis—testicular cancer	0.0189	0.0565	CbGeAlD
Oxtriphylline—PDE4B—G alpha (s) signalling events—INSL3—testicular cancer	0.0182	0.0286	CbGpPWpGaD
Oxtriphylline—ADORA2A—gonad—testicular cancer	0.0181	0.054	CbGeAlD
Oxtriphylline—PDE4D—female gonad—testicular cancer	0.0178	0.0532	CbGeAlD
Oxtriphylline—PDE4D—testis—testicular cancer	0.0158	0.0472	CbGeAlD
Oxtriphylline—PDE4A—female gonad—testicular cancer	0.0157	0.047	CbGeAlD
Oxtriphylline—ADORA2B—testis—testicular cancer	0.0156	0.0468	CbGeAlD
Oxtriphylline—HDAC2—gonad—testicular cancer	0.0154	0.0461	CbGeAlD
Oxtriphylline—ADORA2A—G alpha (s) signalling events—INSL3—testicular cancer	0.0142	0.0224	CbGpPWpGaD
Oxtriphylline—HDAC2—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.0142	0.0223	CbGpPWpGaD
Oxtriphylline—PDE4A—testis—testicular cancer	0.0139	0.0417	CbGeAlD
Oxtriphylline—PDE3B—lymph node—testicular cancer	0.0137	0.041	CbGeAlD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—MAD1L1—testicular cancer	0.0136	0.0214	CbGpPWpGaD
Oxtriphylline—ADORA2A—testis—testicular cancer	0.013	0.039	CbGeAlD
Oxtriphylline—PDE3A—female gonad—testicular cancer	0.013	0.0389	CbGeAlD
Oxtriphylline—SLC22A7—testis—testicular cancer	0.0129	0.0386	CbGeAlD
Oxtriphylline—HDAC2—female gonad—testicular cancer	0.0125	0.0375	CbGeAlD
Oxtriphylline—PDE4B—gonad—testicular cancer	0.0115	0.0345	CbGeAlD
Oxtriphylline—PDE3A—testis—testicular cancer	0.0115	0.0345	CbGeAlD
Oxtriphylline—PDE4D—lymph node—testicular cancer	0.0114	0.0342	CbGeAlD
Oxtriphylline—ADORA1—testis—testicular cancer	0.0112	0.0336	CbGeAlD
Oxtriphylline—HDAC2—testis—testicular cancer	0.0111	0.0332	CbGeAlD
Oxtriphylline—PDE3B—PI3K Cascade—STK11—testicular cancer	0.0108	0.017	CbGpPWpGaD
Oxtriphylline—SLC22A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0103	0.0163	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0103	0.0163	CbGpPWpGaD
Oxtriphylline—PDE4A—lymph node—testicular cancer	0.0101	0.0302	CbGeAlD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00946	0.0149	CbGpPWpGaD
Oxtriphylline—PDE4B—female gonad—testicular cancer	0.00938	0.028	CbGeAlD
Oxtriphylline—PDE3B—IRS-mediated signalling—STK11—testicular cancer	0.00904	0.0142	CbGpPWpGaD
Oxtriphylline—PDE3B—IRS-related events—STK11—testicular cancer	0.00879	0.0138	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00877	0.0138	CbGpPWpGaD
Oxtriphylline—PDE3B—IRS-related events triggered by IGF1R—STK11—testicular cancer	0.00871	0.0137	CbGpPWpGaD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—KITLG—testicular cancer	0.0087	0.0137	CbGpPWpGaD
Oxtriphylline—PDE3B—IGF1R signaling cascade—STK11—testicular cancer	0.00848	0.0134	CbGpPWpGaD
Oxtriphylline—PDE3B—Insulin receptor signalling cascade—STK11—testicular cancer	0.00848	0.0134	CbGpPWpGaD
Oxtriphylline—PDE3A—lymph node—testicular cancer	0.00836	0.025	CbGeAlD
Oxtriphylline—PDE4B—testis—testicular cancer	0.00832	0.0249	CbGeAlD
Oxtriphylline—HDAC2—Cell Cycle—MAD1L1—testicular cancer	0.0082	0.0129	CbGpPWpGaD
Oxtriphylline—ADORA1—lymph node—testicular cancer	0.00815	0.0244	CbGeAlD
Oxtriphylline—HDAC2—lymph node—testicular cancer	0.00805	0.0241	CbGeAlD
Oxtriphylline—ADORA2B—GPCR ligand binding—INSL3—testicular cancer	0.00786	0.0124	CbGpPWpGaD
Oxtriphylline—PDE3B—PI3K Cascade—FGFR3—testicular cancer	0.00743	0.0117	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by Insulin receptor—STK11—testicular cancer	0.00705	0.0111	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00677	0.0107	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—INSL3—testicular cancer	0.00668	0.0105	CbGpPWpGaD
Oxtriphylline—PDE3B—IRS-mediated signalling—FGFR3—testicular cancer	0.00621	0.00979	CbGpPWpGaD
Oxtriphylline—PDE3B—IRS-related events—FGFR3—testicular cancer	0.00604	0.00952	CbGpPWpGaD
Oxtriphylline—PDE4B—lymph node—testicular cancer	0.00603	0.018	CbGeAlD
Oxtriphylline—PDE3B—IRS-related events triggered by IGF1R—FGFR3—testicular cancer	0.00599	0.00943	CbGpPWpGaD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—KIT—testicular cancer	0.00594	0.00935	CbGpPWpGaD
Oxtriphylline—PDE3B—IGF1R signaling cascade—FGFR3—testicular cancer	0.00583	0.00919	CbGpPWpGaD
Oxtriphylline—PDE3B—Insulin receptor signalling cascade—FGFR3—testicular cancer	0.00583	0.00919	CbGpPWpGaD
Oxtriphylline—HDAC2—NoRC negatively regulates rRNA expression—H2AFZ—testicular cancer	0.00572	0.00901	CbGpPWpGaD
Oxtriphylline—HDAC2—RNA Polymerase I Promoter Clearance—H2AFZ—testicular cancer	0.00559	0.0088	CbGpPWpGaD
Oxtriphylline—HDAC2—Negative epigenetic regulation of rRNA expression—H2AFZ—testicular cancer	0.00559	0.0088	CbGpPWpGaD
Oxtriphylline—HDAC2—RNA Polymerase I Transcription—H2AFZ—testicular cancer	0.0055	0.00867	CbGpPWpGaD
Oxtriphylline—HDAC2—Cell Cycle—KITLG—testicular cancer	0.00526	0.00829	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00524	0.00826	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—INSL3—testicular cancer	0.00516	0.00813	CbGpPWpGaD
Oxtriphylline—HDAC2—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.00496	0.00781	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—INSL3—testicular cancer	0.00487	0.00766	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by Insulin receptor—FGFR3—testicular cancer	0.00485	0.00763	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—INSL3—testicular cancer	0.00444	0.00699	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—INSL3—testicular cancer	0.00442	0.00696	CbGpPWpGaD
Oxtriphylline—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—H2AFZ—testicular cancer	0.00439	0.00691	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—INSL3—testicular cancer	0.00431	0.00678	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—INSL3—testicular cancer	0.00424	0.00667	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—INSL3—testicular cancer	0.00403	0.00635	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—INSL3—testicular cancer	0.00403	0.00635	CbGpPWpGaD
Oxtriphylline—HDAC2—Neural Crest Differentiation—FGFR3—testicular cancer	0.00394	0.00621	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—INSL3—testicular cancer	0.00392	0.00618	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—INSL3—testicular cancer	0.00391	0.00616	CbGpPWpGaD
Oxtriphylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.00386	0.00609	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—INSL3—testicular cancer	0.00385	0.00606	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.00382	0.00601	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—INSL3—testicular cancer	0.00378	0.00595	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—INSL3—testicular cancer	0.00373	0.00588	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—INSL3—testicular cancer	0.00366	0.00577	CbGpPWpGaD
Oxtriphylline—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00357	0.00563	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—INSL3—testicular cancer	0.00356	0.00561	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—INSL3—testicular cancer	0.00343	0.0054	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—INSL3—testicular cancer	0.00339	0.00534	CbGpPWpGaD
Oxtriphylline—HDAC2—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00313	0.00492	CbGpPWpGaD
Oxtriphylline—HDAC2—Transcription—H2AFZ—testicular cancer	0.00297	0.00468	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—INSL3—testicular cancer	0.00291	0.00459	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00279	0.00439	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—INSL3—testicular cancer	0.00265	0.00417	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—INSL3—testicular cancer	0.00261	0.00411	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—MMP2—testicular cancer	0.00247	0.00389	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—INSL3—testicular cancer	0.00238	0.00375	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—DNMT3L—testicular cancer	0.00237	0.00373	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—INSL3—testicular cancer	0.00231	0.00364	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—KITLG—testicular cancer	0.00231	0.00363	CbGpPWpGaD
Oxtriphylline—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.00227	0.00358	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—INSL3—testicular cancer	0.00227	0.00358	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—INSL3—testicular cancer	0.00216	0.00341	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—KITLG—testicular cancer	0.00214	0.00338	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—INSL3—testicular cancer	0.0021	0.00331	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.00207	0.00326	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—INSL3—testicular cancer	0.00203	0.00319	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—INSL3—testicular cancer	0.002	0.00315	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.0019	0.003	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—FGFR3—testicular cancer	0.00171	0.0027	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—INSL3—testicular cancer	0.00168	0.00265	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—FGFR3—testicular cancer	0.00159	0.00251	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—KIT—testicular cancer	0.00157	0.00248	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—INSL3—testicular cancer	0.00156	0.00246	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—KIT—testicular cancer	0.00146	0.0023	CbGpPWpGaD
Oxtriphylline—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.00133	0.00209	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—H2AFZ—testicular cancer	0.000836	0.00132	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—STK11—testicular cancer	0.000831	0.00131	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—H2AFZ—testicular cancer	0.000828	0.0013	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—H2AFZ—testicular cancer	0.000769	0.00121	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KITLG—testicular cancer	0.000769	0.00121	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—H2AFZ—testicular cancer	0.000762	0.0012	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—STK11—testicular cancer	0.000758	0.00119	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—H2AFZ—testicular cancer	0.000739	0.00116	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—STK11—testicular cancer	0.000735	0.00116	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—H2AFZ—testicular cancer	0.000727	0.00115	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—STK11—testicular cancer	0.000723	0.00114	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KITLG—testicular cancer	0.000707	0.00111	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KITLG—testicular cancer	0.000701	0.0011	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—H2AFZ—testicular cancer	0.000692	0.00109	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—STK11—testicular cancer	0.000688	0.00108	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KITLG—testicular cancer	0.00068	0.00107	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—H2AFZ—testicular cancer	0.000673	0.00106	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—STK11—testicular cancer	0.00067	0.00105	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KITLG—testicular cancer	0.000669	0.00105	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—H2AFZ—testicular cancer	0.000648	0.00102	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—STK11—testicular cancer	0.000645	0.00102	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—H2AFZ—testicular cancer	0.000641	0.00101	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—STK11—testicular cancer	0.000637	0.001	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KITLG—testicular cancer	0.000637	0.001	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KITLG—testicular cancer	0.00062	0.000976	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KITLG—testicular cancer	0.000596	0.000939	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KITLG—testicular cancer	0.000589	0.000928	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—FGFR3—testicular cancer	0.000571	0.0009	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—H2AFZ—testicular cancer	0.000538	0.000848	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—STK11—testicular cancer	0.000535	0.000843	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—FGFR3—testicular cancer	0.000526	0.000828	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KIT—testicular cancer	0.000525	0.000826	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—FGFR3—testicular cancer	0.000521	0.000821	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00051	0.000804	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—FGFR3—testicular cancer	0.000506	0.000796	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—H2AFZ—testicular cancer	0.000501	0.000788	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—STK11—testicular cancer	0.000498	0.000784	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—FGFR3—testicular cancer	0.000497	0.000783	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KITLG—testicular cancer	0.000495	0.00078	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KIT—testicular cancer	0.000483	0.00076	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KIT—testicular cancer	0.000479	0.000754	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—FGFR3—testicular cancer	0.000473	0.000746	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KIT—testicular cancer	0.000464	0.000731	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KITLG—testicular cancer	0.00046	0.000725	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—FGFR3—testicular cancer	0.00046	0.000725	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KIT—testicular cancer	0.000457	0.000719	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FGFR3—testicular cancer	0.000443	0.000698	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FGFR3—testicular cancer	0.000438	0.00069	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KIT—testicular cancer	0.000435	0.000685	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KIT—testicular cancer	0.000423	0.000666	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KIT—testicular cancer	0.000407	0.000641	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KIT—testicular cancer	0.000402	0.000633	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FGFR3—testicular cancer	0.000368	0.00058	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FGFR3—testicular cancer	0.000342	0.000539	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KIT—testicular cancer	0.000338	0.000532	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KIT—testicular cancer	0.000314	0.000495	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HPGDS—testicular cancer	0.000227	0.000358	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—STK11—testicular cancer	0.000165	0.00026	CbGpPWpGaD
